home / stock / vtgn / vtgn news


VTGN News and Press, VistaGen Therapeutics Inc. From 02/18/21

Stock Information

Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com

Menu

VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...

VTGN - VistaGen initiated with Buy at Jefferies on 'upside potential' for anxiety drug

Vistagen Therapeutics (VTGN) jumps 13% premarket after Jefferies initiated coverage with a Buy rating and price target of $6.Analyst Andrew Tsai says that company's lead asset, PH94B, a fast-acting nasal spray had compelling Phase II data and could become the first FDA-approved trea...

VTGN - VistaGen Therapeutics EPS misses by $0.02, beats on revenue

VistaGen Therapeutics (VTGN): Q3 GAAP EPS of -$0.07 misses by $0.02.Revenue of $0.31M beats by $0.14M.Press Release For further details see: VistaGen Therapeutics EPS misses by $0.02, beats on revenue

VTGN - VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021

Multiple clinical studies anticipated to launch in Calendar 2021, notably pivotal Phase 3 clinical studies of PH94B as a potential acute treatment of anxiety in adults with social anxiety disorder (SAD) Strengthened Balance Sheet upon closing of $100 million underwritten public ...

VTGN - VistaGen: Patience Could Lead To Significant Upside

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a generation of novel medicines for anxiety, depression, and other central nervous system disorders, primarily through nasal sprays. VistaGen has three therapeutics in their pipeline across...

VTGN - VistaGen Therapeutics regains Nasdaq listing compliance

VistaGen Therapeutics (VTGN) has received a notice from Nasdaq that it has regained compliance with the minimum bid price requirement for continued listing.The company is now in full compliance with all applicable listing standards, and Nasdaq considers the matter closed. For further detail...

VTGN - VistaGen Therapeutics Regains Full Compliance with Nasdaq Listing Requirements

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central...

VTGN - VistaGen Announces Publication in CNS Spectrums Detailing Proposed Mechanism of Action of Its Investigational Neuroactive Nasal Sprays for Anxiety and Depression Disorders

SOUTH SAN FRANCISCO, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) -- VistaGen Therapeutics , Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other ce...

VTGN - Penny Stocks Analysts Say Buy With 92%-284% Price Targets

Penny Stocks With Big Price Targets Whether you’re looking for penny stocks to buy on Robinhood, ETrade, TD, Webull, Interactive Brokers, or other platforms, everyone has 1 goal. At least I would hope everyone has one goal, which is to make money. One of the interesting p...

VTGN - VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) --  VistaGen Therapeutics, Inc. (NASDAQ: VTGN) (“VistaGen”), a biopharmaceutical company committed to developing a new generation of medicines with potential to go beyond the current standard of care for anxiety,...

VTGN - 5 Penny Stocks To Watch Before Next Week

Can These 5 Penny Stocks Continue to Rally? Throughout the month of December, investors have seen a lot of positive sentiment with penny stocks . While trading these stocks has changed in 2020, the majority of the factors remain largely the same. This includes understanding the fund...

Previous 10 Next 10